GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
2,650
Funds Holding Change
0
Funds Holding Growth
0%
Value
$509B
Holding in Top 10
544
Top 10 Change
-48
Top 10 Growth
-8%
Value Growth
+0.1%
New
111
Increased
1,208
Reduced
1,120
Closed
83
Capital Inflow
$20.1B
Capital Outflow
$20.6B
Net Capital Flow
-$580M
Capital Flow Change
+$4.05B
Calls
$8.21B
Puts
$7.51B
Net Calls
+$695M
Put/Call Ratio
0.92